156 related articles for article (PubMed ID: 12834609)
1. BRCA1 expression in canine mammary dysplasias and tumours: relationship with prognostic variables.
Nieto A; Pérez-Alenza MD; Del Castillo N; Tabanera E; Castaño M; Peña L
J Comp Pathol; 2003 May; 128(4):260-8. PubMed ID: 12834609
[TBL] [Abstract][Full Text] [Related]
2. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
3. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
4. Expression of Cox-1 and Cox-2 in canine mammary tumours.
Queiroga FL; Alves A; Pires I; Lopes C
J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
[TBL] [Abstract][Full Text] [Related]
5. Detection of matrix metalloproteinases in canine mammary tumours: analysis by immunohistochemistry and zymography.
Hirayama K; Yokota H; Onai R; Kobayashi T; Kumata T; Kihara K; Okamoto M; Sako T; Nakade T; Izumisawa Y; Taniyama H
J Comp Pathol; 2002 Nov; 127(4):249-56. PubMed ID: 12443732
[TBL] [Abstract][Full Text] [Related]
6. Expression of fibronectin and its integrin receptor alpha 5 beta 1 in canine mammary tumours.
Peña L; Nieto A; Perez Alenza MD; Rodriguez A; Sanchez MA; Castaño M
Res Vet Sci; 1994 Nov; 57(3):358-64. PubMed ID: 7871257
[TBL] [Abstract][Full Text] [Related]
7. Mucin 6 and Tn antigen expression in canine mammary tumours: correlation with pathological features.
Tavares C; de Oliveira JT; Lopes C; Carvalheira J; Matos AJ; Rutteman G; Reis CA; Gärtner F
J Comp Pathol; 2012 Nov; 147(4):410-8. PubMed ID: 22595635
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
Amorim I; Lopes CC; Faustino AM; Pereira PD
J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
[TBL] [Abstract][Full Text] [Related]
9. Expression of Breast Cancer Resistance Protein (BCRP-1) in canine mammary adenocarcinomas and adenomas.
Nowak M; Madej JA; Dziegiel P
In Vivo; 2009; 23(5):705-9. PubMed ID: 19779104
[TBL] [Abstract][Full Text] [Related]
10. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
11. Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
Faustino AM; van Garderen E; Schalken JA; Nederbragt H
J Comp Pathol; 2002 Jan; 126(1):1-8. PubMed ID: 11814316
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical distribution of type IV collagenase in normal, dysplastic and neoplastic canine mammary gland.
Papparella S; Restucci B; Maiolino P; De Vico G
J Comp Pathol; 1997 Oct; 117(3):277-82. PubMed ID: 9447489
[TBL] [Abstract][Full Text] [Related]
13. Cellular proliferative and telomerase activity in canine mammary gland tumors.
Funakoshi Y; Nakayama H; Uetsuka K; Nishimura R; Sasaki N; Doi K
Vet Pathol; 2000 Mar; 37(2):177-83. PubMed ID: 10714647
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
15. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
[TBL] [Abstract][Full Text] [Related]
16. Tenascin expression in relation to stromal tumour cells in canine gastrointestinal epithelial tumours.
Mukaratirwa S; de Witte E; van Ederen AM; Nederbragt H
J Comp Pathol; 2003; 129(2-3):137-46. PubMed ID: 12921719
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein expression in canine and feline mammary and melanotic tumours.
Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
[TBL] [Abstract][Full Text] [Related]
18. Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas.
Michel E; Feldmann SK; Kowalewski MP; Bley CR; Boos A; Guscetti F; Reichler IM
BMC Vet Res; 2012 May; 8():72. PubMed ID: 22647582
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors.
Sánchez-Céspedes R; Fernández-Martínez MD; Raya A; Pineda C; López I; Millán Y
Vet Comp Oncol; 2018 Mar; 16(1):E185-E193. PubMed ID: 29178579
[TBL] [Abstract][Full Text] [Related]
20. Decorin concentrations in canine normal and neoplastic mammary gland tissues.
Szczubiał M; Kankofer M; Wawrzykowski J; Dąbrowski R; Łopuszyński W; Bochniarz M; Brodzki P
Reprod Domest Anim; 2020 Oct; 55(10):1404-1410. PubMed ID: 33470009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
